← Back to Screener
CeriBell, Inc. Common Stock (CBLL)
Price$18.25
Value ScoreD
Growth ScoreA
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-0.38%
Price vs S&P 500 (4W)-9.64%
VGM Score57.75
Market Capitalization$692.45M
All Metrics
Book Value / Share (Quarterly)$3.72
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)50.90%
Cash Flow / Share (Quarterly)$-1.34
Price vs S&P 500 (YTD)-24.94%
Gross Margin (TTM)87.72%
Net Profit Margin (TTM)-63.51%
EPS (TTM)$-1.63
10-Day Avg Trading Volume0.24M
EPS Excl Extra (TTM)$-1.63
EPS (Annual)$-1.46
ROI (Annual)-30.50%
Gross Margin (Annual)87.89%
Cash / Share (Quarterly)$3.73
Revenue Growth QoQ (YoY)29.30%
ROA (Last FY)-27.28%
EBITD / Share (TTM)$-1.72
Operating Margin (TTM)-68.31%
Cash Flow / Share (Annual)$-1.13
P/B Ratio4.92x
P/B Ratio (Quarterly)4.90x
Net Income / Employee (Annual)$-163,300
EV / Revenue (TTM)7.02x
Net Interest Coverage (TTM)-27.26x
ROA (TTM)-30.92%
EPS Incl Extra (Annual)$-1.46
Current Ratio (Annual)9.73x
Quick Ratio (Quarterly)9.83x
3-Month Avg Trading Volume0.30M
52-Week Price Return4.29%
Revenue / Employee (TTM)$290,700
P/S Ratio (Annual)7.77x
Asset Turnover (Annual)0.45x
52-Week High$24.33
EPS Excl Extra (Annual)$-1.46
26-Week Price Return7.54%
Quick Ratio (Annual)9.20x
13-Week Price Return2.01%
Total Debt / Equity (Annual)0.13x
Current Ratio (Quarterly)10.44x
Enterprise Value$667.12M
Asset Turnover (TTM)0.49x
Revenue / Employee (Annual)$272,400
Inventory Turnover (Annual)1.52x
Pretax Margin (Annual)-59.97%
Cash / Share (Annual)$4.25
3-Month Return Std Dev57.53%
Net Income / Employee (TTM)$-184,600
ROE (Last FY)-34.38%
Net Interest Coverage (Annual)-31.58x
EPS Basic Excl Extra (Annual)$-1.46
Receivables Turnover (TTM)6.08x
Total Debt / Equity (Quarterly)0.14x
EPS Incl Extra (TTM)$-1.63
Receivables Turnover (Annual)5.94x
ROI (TTM)-33.94%
P/S Ratio (TTM)7.28x
Revenue / Share (Annual)$2.44
Price vs S&P 500 (52W)-20.08%
Year-to-Date Return-16.78%
5-Day Price Return3.63%
EPS Normalized (Annual)$-1.46
Net Profit Margin (Annual)-59.97%
Month-to-Date Return-1.08%
EBITD / Share (Annual)$-1.56
Operating Margin (Annual)-65.57%
LT Debt / Equity (Annual)0.13x
LT Debt / Equity (Quarterly)0.14x
EPS Basic Excl Extra (TTM)$-1.63
P/B Ratio (Annual)5.24x
Inventory Turnover (TTM)1.74x
Pretax Margin (TTM)-63.51%
Book Value / Share (Annual)$4.14
Price vs S&P 500 (13W)-6.24%
Beta1.19x
Revenue / Share (TTM)$2.52
ROE (TTM)-38.19%
52-Week Low$10.85
vGradeD
gGradeA
mGradeB
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.52est. -0.40
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.43
4.43
4.43
4.43
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CBLLCeriBell, Inc. Common Stock | D | A | B | $18.25 |
| MDTMedtronic plc | B | C | C | $81.67 |
| MASIMasimo Corporation | D | D | B | $178.82 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $72.36 |
| ITGRInteger Holdings Corporation | B | C | C | $91.98 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | $69.43 |
| AXGNAxogen, Inc. Common Stock | F | B | A | $42.80 |
| BLFSBioLife Solutions Inc. | F | B | B | $26.65 |
| CNMDCONMED Corporation | A | C | D | $35.16 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | $13.54 |
| CVCapsoVision, Inc. Common Stock | F | D | A | $7.19 |
About
CeriBell Inc. develops portable point-of-care EEG systems for rapid neurological diagnosis in acute care settings. The company's Ceribell System combines proprietary hardware with AI algorithms to address critical diagnostic needs. Products include Point-of-Care EEG devices, Clarity analytics software, and the EEG Portal platform.